Menu

Blog

Jun 9, 2024

Scientists develop new CRISPR gene editing platform for precision medicine and cancer treatment

Posted by in categories: bioengineering, biotech/medical

Researchers at Columbia University College of Dental Medicine have developed an exosome-based platform, “safeEXO-Cas,” that significantly enhances the delivery of CRISPR/Cas9 genome editing components to specific cells and tissues.

Leave a reply